Summary:
An update for unbound is now available for EulerOS Virtualization release 2.10.1
EulerOS Security has rated this update as having a security impact of Critical.A Common Vunlnerability Scoring System(CVSS)base score, which gives a detailed severity rating, is available for each vulnerability from the CVElink(s) in the References section.General:
Unbound is a validating, recursive, and caching DNS(SEC) resolver. The C implementation of Unbound is developed and maintained by NLnet Labs. It is based on ideas and algorithms taken from a java prototype developed by Verisign labs, Nominet, Kirei and ep.net. Unbound is designed as a set of modular components, so that also DNSSEC (secure DNS) validation and stub-resolvers (that do not run as a server, but are linked into an application) are easily possible.
Security Fix(es):
In NLnet Labs Unbound 1.7.0 up to and including 1.25.1, insufficient validation of the RRSIG.Labels field combined with premature cache writes during RFC 8198 aggressive NSEC processing leads to cache poisoning that permits a malicious actor controlling a single delegated zone to poison arbitrary sibling zones under NSEC-signed parent domains. A malicious actor with one registered domain under an NSEC-signed TLD can serve malicious insecure DNS responses for unrelated sibling domains (sharing the same parent zone). Arbitrary delegations that do not exist under the parent domain and are covered by the parent's NSEC chain can be brought into insecure existence by fraudulent wildcard DS records (less labels than expected, unknown algorithm) from the malicious sibling domain. This allows the malicious actor to inject insecure wildcard records for those delegations.(CVE-2026-44690)
In NLnet Labs Unbound 1.4.22 up to and including 1.25.1, UDP source port is randomized and intended to serve as a secret value that increases the entropy of DNS transactions. When resolver load balancing policies depend on the source port while their...
1.11.0-2.h22.eulerosv2r101.11.0-2.h22.eulerosv2r10Exploitability
AV:NAC:LPR:NUI:NScope
S:UImpact
C:HI:HA:H9.8/CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H